New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
1 hedge funds and large institutions have $190K invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
95% less ownership
Funds ownership: 190% → 95% (-95%)
98% less capital invested
Capital invested by funds: $9.56M → $190K (-$9.37M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSL
Mackay Shields LLC
New York
|
-$4.78M |
LRND Hedge Fund Activity: Q2 2022 in Review
1 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q2 2022, worth a combined $190K — down 98% from $9.56M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LRND and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Mackay Shields LLC, exiting entirely with an estimated $4.78M sold.
- 1 institutional investor held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q2 2022, down from 2 in Q1 2022.
- Funds reported $190K of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q2 2022, down 98% quarter-over-quarter.
- 0 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF seller in Q2 2022 was Mackay Shields LLC, an estimated $4.78M sold.
Based on aggregated 13F filings for Q2 2022.